Dr. Laura J. Donlan, DDS ,
-
A New Oral Gonorrhea Drug Won FDA Approval. What the Zoliflodacin Trial Actually Found
The FDA has approved Nuzolvence, an oral form of zoliflodacin, for some uncomplicated gonorrhea cases. Here is what the phase 3 trial found, what noninferior means, and why this does not apply to every gonorrhea infection.
-
County Advances Safety-Net Health Overhaul as Budget and Behavioral Health Plans Open for Input
San Diego, CA – March 7, 2026 – County leaders move to revamp a safety-net health program as budget input opens and behavioral health planning advances countywide.
-
What Are Infectious Diseases? Common Types and How They Spread
This article explains what infectious diseases are, the most common types (viral, bacterial, fungal, and parasitic), and how they spread through everyday routes like respiratory droplets, touch, food and water, blood and body fluids, and insects or animals. It highlights familiar examples, clears up myths (such as why antibiotics don’t work for viruses), and offers practical steps to protect yourself and your family—vaccination, hand hygiene, masks and ventilation, safe food and water, safer sex, and staying home when sick. Designed for patients and caregivers, it also outlines when to seek care and how early testing and treatment can limit complications, making it a reliable, reassuring guide for everyday health decisions.
-
Latest Advances in Neurology in 2025: Treatments Changing Patient Care
In 2025, neurology is shifting toward earlier, more personalized, and less invasive care that meaningfully improves daily life. Blood-based biomarkers and AI-enhanced imaging are speeding diagnosis and helping match patients to the right treatments, while disease‑modifying options are expanding—from anti‑amyloid therapies for Alzheimer’s and genetics‑guided approaches in ALS to next‑generation therapies for MS and new migraine preventives. Targeted neuromodulation and wearable monitoring are reducing symptoms and hospital visits in epilepsy and movement disorders, and stroke care is faster and more effective with streamlined thrombolysis, improved thrombectomy, and home‑based rehabilitation. For patients, caregivers, and information seekers, these advances translate into clearer choices, more care delivered at home, better function with fewer side effects, and greater access to clinical trials when standard options are limited.